Lupin Pharmaceuticals Inc. recalls Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in a) 90-count bottles (NDC 68180-249-09 and b) 500-co
Recalled December 25, 2019 · FDA recall D-0629-2020 · Lupin Pharmaceuticals
Hazard
Failed Dissolution Specifications: High out of specification result observed at stability studies. · FDA Class III
Units
3,726 bottles
Sold at
Nationwide in the USA
Description
Failed Dissolution Specifications: High out of specification result observed at stability studies.
Product
Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in a) 90-count bottles (NDC 68180-249-09 and b) 500-count bottles (NDC 68180-249-02); Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Pithampur (M.P.)-454 775, INDIA
Manufacturer(s)
Lupin Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →